In pre-clinical models of allergic asthma and allergic conjunctivitis, rEV131 has been shown to bind histamine very tightly and block mast-cell degranulation, reducing itching and inflammation associated with histamine release in the allergic response 31 ( Chapin M et al
Ingredients: Water, Butylene Glycol, Niacinamide, Panthenol, Tranexamic Acid, 1,2-Hexanediol, Neopentyl Glycol Dicaprate, Caprylic/Capric Triglyceride, Sorbitol, Vaccinium Vitis-Idaea Fruit Extract, Chondrus Crispus Extract, Butyrospermum Parkii Butter, Saccharum Officinarum Extract, Alpha-Arbutin, Bifida Ferment Lysate, Sodium Hyaluronate, Melia Azadirachta Flower Extract, Ocimum Sanctum Leat Extract, Melia Azadirachta Leaf Extract, Curcuma Longa Root Extract, Corallina Officinalis Extract, Tremella Fuciformis Extract, Pentylene Glycol, Glycerin, 3-O-Ethyl Ascorbic Acid, Bisabolol, Tromethamine, Ethylhexylglycerin, Adenosine, Hydrogenated Lecithin, Allantoin, Glutathione, Ceramide NP, Beta-Glucan, Dipotassium Glycyrrhizate, Tocopherol, Ascorbic Acid, Ascorbyl Glucoside, Tocopheryl Acetate, Hydroxypropyl Cyclodextrin, Ubiquinone, Thioctic Acid, Potassium Hydroxide, Behenyl Alcohol, Carbomer, Xanthan Gum, Disodium EDTA
Although sufficient experiments have been carried out in the present work, including experiments that confirm the favorable properties of the D/S@SPMM material and its tumor treatment efficiency in vivo and in vitro , there are still shortcomings
can be applied multiple times a day as needed for glow or hydration
both were fully described so that the former could support the interpretation of the latter
Su P, Aschner M, Chen J, Luo W
